Europe Orthobiologics Market - Industry Trends and Forecast to 2026

  • Medical Devices
  • Upcoming Report
  • Oct 2019
  • Europe
  • 150 Pages
  • No of Tables: 30
  • No of Figures: 50

Europe Orthobiologics Market By Products (Demineralized Bone Matrix (DBM), Allograft, Bone Morphogenetic Protein (BMP), Viscosupplementation, Synthetic Bone Substitutes, Stem Cell Therapy, Bone Marrow Aspirate Protein, Plasma-Rich Protein, Other Products), Application (Spinal Fusion, Trauma Repair, Reconstructive Surgery, Tendon And Ligament, Osteoarthritis and Degenerative Arthritis, Soft-Tissue Injuries, Fracture Recovery, Maxillofacial and Dental Applications, Others), By Type ( Knee, Ankle, Hip, Wrist & Shoulder, Spine, Others), By End-User (Hospitals, Orthopedic Clinics & Ambulatory Care Centers, Research & Academic Institutes, Dental Clinics and Facilities), Country (Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest Of Europe) - Industry Trends and Forecast to 2026

Market Analysis: Europe Orthobiologics Market

Europe orthobiologics market is registering a substantial CAGR of 5.96% in the forecast period of 2019-2026. This rise in the market value can be attributed to the surging orthopedic related diseases due to lifestyle choices and increased consciousness among individuals due to orthobiological advantages.

Market Definition: Europe Orthobiologics Market

Orthobiologics are drugs that are used by orthopedic surgeons to assist cure wounds faster. They are used to enhance regeneration of damaged joints and tissues, tendons and ligaments that have been wounded. These products are produced of normally occurring drugs in your flesh. Using orthobiologics drugs in greater levels helps speed up the healing process. Some main advantages connected with conservative orthobiologics therapies include minimizing the effect of degenerative disease, completing all processes as an outpatient in the workplace, and regeneration is faster than surgery.

Market Drivers

  • Growing old population, is driving the growth of the market
  • Surging orthopedic related diseases due to lifestyle choices, is propelling the growth of the market
  • Technological advancement in the orthobiologics, is boosting the growth of the market
  • Increased consciousness among individuals due to orthobiological advantages, is contributing to the growth of the market

Market Restraints

  • Strict government guidelines, are restricting the growth of the market.
  • Post-surgery difficulties, is hindering the growth of the market
  • High charge of orthopedic implants, is hampering the growth of the market,

Segmentation: Europe Orthobiologics Market

By Products

  • Demineralized bone matrix (DBM)
  • Allograft
  • Bone morphogenetic protein (BMP)
  • Viscosupplementation
  • Synthetic bone substitutes
  • Stem cell therapy
  • Bone Marrow Aspirate Protein
  • Plasma-Rich Protein
  • Other Products

By Application

  • Spinal fusion
  • Trauma repair
  • Reconstructive surgery
  • Tendon and ligament
  • Osteoarthritis and Degenerative Arthritis
  • Soft-Tissue Injuries
  • Fracture Recovery
  • Maxillofacial and Dental Applications
  • Others

By Type

  • Knee
  • Ankle
  • Hip
  • Wrist & Shoulder
  • Spine
  • Others

By End-User

  • Hospitals
  • Orthopedic clinics & Ambulatory Care Centers
  • Research & Academic Institutes
  • Dental Clinics and Facilities

By Country

  • Germany
  • Italy
  • U.K.
  • France
  • Spain
  • Netherlands
  • Belgium
  • Switzerland
  • Turkey
  • Russia
  • Rest of Europe

Key Developments in the Market:

  • In March 2019, Fidia is launching its first regenerative medicine drug, NuDYN. NuDYN is an allograft derived from purchased placentas acquired through cesarean delivery, which is shelf-stable, injectable, flow able, amniotic membrane. It is designed to be acellular to enable shelf-stable retention while maintaining the amniotic membrane's useful inherent characteristics including hyaluronic acid, collagen, and growth factors. These allograft's unique characteristics provide safety, lubrication, and help advantages.
  • In December 2016, Kuros Biosciences will purchase Xpand Biotechnology through a structured share-swapping agreement. The synthetic surface science technique of Xpand and the biologics module of Kuros for fibrin / PTH. The extension will also provide it with an EU procedure and accredited GMP equipment. With this purchase, the firm will have major orthobiological products in important sections and the chance to create an embedded business with successful products on the ground and in production.

Competitive Analysis:

Europe orthobiologics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of orthobiologics market for Europe.

Key Market Competitors:

Few of the major market competitors currently working in the Europe orthobiologics market are  Baxter, CONMED Corporation, DePuy Synthes, Exactech, Inc., Integra LifeSciences Corporation, Medtronic, NuVasive, Inc., RTI Surgical Holdings, Inc., Sanofi, Smith & Nephew, Stryker, Zimmer Biomet, SINTX Technologies, Inc., AlloSource,  and others.

Research Methodology:  Europe Orthobiologics Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others

Reasons to Purchase this Report

  • Current and future of Europe orthobiologics market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


SKU-

Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
BUY NOW ADD TO CART
Why Choose Us
REQUEST FOR SAMPLE